NIIMBL Expands Investment in Biopharma Workforce and Innovation

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has selected eight new member-led technology and workforce development projects totaling $9.7 million in NIIMBL funding and member co-investment through its Project Call 9.1. Featuring 39 participating organizations, the projects target major industry challenges to advance domestic biopharmaceutical manufacturing capabilities and talent development strategies.

"These new technology projects represent the kind of innovation needed to strengthen the nation's biopharmaceutical manufacturing capabilities, said Sandeep Kedia, NIIMBL Senior Technology Fellow and Project Call Program Lead. "By bringing together advanced process analytical technologies, AI-driven optimization, and next-generation production platforms, our members are helping accelerate the adoption of transformative technologies across the industry."

Three workforce initiatives will spark interest in biopharmaceutical manufacturing careers, strengthen cross-regional workforce partnerships, and build an AI-ready biopharmaceutical manufacturing workforce, helping ensure the United States maintains global leadership in biopharma talent.

"Our workforce initiatives are designed to meet talent needs head‑on by creating more innovative pathways into biomanufacturing careers, said John Balchunas, NIIMBL Workforce Director. "These new projects will strengthen partnerships and ensure that learners can gain the skills needed to thrive in a rapidly evolving biopharma industry."